Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6327)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2014 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ladep NG, Khan SA, Crossey MM, Thillainayagam AV, Taylor-Robinson SD, Toledano MB. Incidence and mortality of primary liver cancer in England and Wales: Changing patterns and ethnic variations. World J Gastroenterol 2014; 20(6): 1544-1553 [PMID: 24587630 DOI: 10.3748/wjg.v20.i6.1544] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i6/1544.htm |
| Number | Citing Articles |
| 1 |
Richard A. Burkhart, Sean M. Ronnekleiv-Kelly, Timothy M. Pawlik. Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response. Surgical Oncology 2017; 26(2): 138 doi: 10.1016/j.suronc.2017.01.009
|
| 2 |
Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2018; 17: 153303381879449 doi: 10.1177/1533033818794494
|
| 3 |
Laith Omar Khalaf Alghazawi, Olivia Holtermann Entwistle, Matyas Fehervari, Duncan Spalding. Unusual cause of intraoperative haemorrhage: a lesson for patient counselling. BMJ Case Reports 2022; 15(6): e247951 doi: 10.1136/bcr-2021-247951
|
| 4 |
Isabella Lurje, Zoltan Czigany, Jan Bednarsch, Christoph Roderburg, Peter Isfort, Ulf Peter Neumann, Georg Lurje. Treatment Strategies for Hepatocellular Carcinoma – a Multidisciplinary Approach. International Journal of Molecular Sciences 2019; 20(6): 1465 doi: 10.3390/ijms20061465
|
| 5 |
Weiqi Liao, Carol A.C. Coupland, Hamish Innes, Peter Jepsen, Philippa C. Matthews, Cori Campbell, Eleanor Barnes, Julia Hippisley-Cox, Eleanor Barnes, Emma Culver, Roman Fischer, Julia Hippisley-Cox, Hamish Innes, William L. Irving, Peter Jepsen, Matt Kelly, Paul Klenerman, Weiqi Liao, Derek Mann, Aileen Marshall, Philippa C. Matthews, Michael Pavlides, Rory J.R. Peters, Elisabeth Pickles, James Robineau, Benjamin Schuster-Böckler, Chunxiao Song, Jeremy Tomlinson, Christopher Welberry. Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database. eClinicalMedicine 2023; 59: 101969 doi: 10.1016/j.eclinm.2023.101969
|
| 6 |
Avik Majumdar, Davide Roccarina, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with early- or very early-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD011650.pub2
|
| 7 |
Hai-Yong Chen, Yao-Min Chen, Jian Wu, Fu-Chun Yang, Zhen Lv, Xiao-Feng Xu, Shu-Sen Zheng. Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer. Medicine 2016; 95(21): e3708 doi: 10.1097/MD.0000000000003708
|
| 8 |
Sarah H. Wild, Joanne R. Morling, David A. McAllister, Jan Kerssens, Colin Fischbacher, Julie Parkes, Paul J. Roderick, Naveed Sattar, Christopher D. Byrne. Type 2 diabetes and risk of hospital admission or death for chronic liver diseases. Journal of Hepatology 2016; 64(6): 1358 doi: 10.1016/j.jhep.2016.01.014
|
| 9 |
Francesca M Trovato, Joshua M Tognarelli, Mary ME Crossey, Daniela Catalano, Simon D Taylor-Robinson, Guglielmo M Trovato. Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World Journal of Hepatology 2015; 7(26): 2664-2675 doi: 10.4254/wjh.v7.i26.2664
|
| 10 |
Kim Tu Tran, Úna C. McMenamin, Helen G. Coleman, Chris R. Cardwell, Peter Murchie, Lisa Iversen, Amanda J. Lee, Aaron P. Thrift. Statin use and risk of liver cancer: Evidence from two population‐based studies. International Journal of Cancer 2020; 146(5): 1250 doi: 10.1002/ijc.32426
|
| 11 |
Davide Roccarina, Avik Majumdar, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with intermediate-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD011649.pub2
|
| 12 |
Jiang Chen, Jie Zhao, Rui Ma, Hui Lin, Xiao Liang, Xiujun Cai, Kwan Man. Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(8): e103952 doi: 10.1371/journal.pone.0103952
|
| 13 |
Meredith E. Pittman. Hepatocellular carcinoma: a practical review for the surgical pathologist. Diagnostic Histopathology 2018; 24(12): 500 doi: 10.1016/j.mpdhp.2018.09.005
|
| 14 |
Anna Roskilly, Ian A Rowe. Surveillance for hepatocellular cancer. Clinical Medicine 2018; 18(2): s66 doi: 10.7861/clinmedicine.18-2-s66
|
| 15 |
Andrea A. Florio, Barry I. Graubard, Baiyu Yang, Jake E. Thistle, Marie C. Bradley, Katherine A. McGlynn, Jessica L. Petrick. Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. European Journal of Epidemiology 2019; 34(9): 871 doi: 10.1007/s10654-019-00526-1
|
| 16 |
Qian Zhang, Kexiang Zhou, Wei Liang, Wei Xiong. Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis. Journal of International Medical Research 2020; 48(10): 030006052096267 doi: 10.1177/0300060520962675
|
| 17 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD011650
|
| 18 |
Mehmet Sayiner, Pegah Golabi, Zobair M. Younossi. Disease Burden of Hepatocellular Carcinoma: A Global Perspective. Digestive Diseases and Sciences 2019; 64(4): 910 doi: 10.1007/s10620-019-05537-2
|
| 19 |
Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, Mohamad Amin Pourhoseingholi. Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study. BMC Public Health 2022; 22(1) doi: 10.1186/s12889-022-12867-w
|
| 20 |
Baiyu Yang, Jessica L. Petrick, Jie Chen, Katrina Wilcox Hagberg, Vikrant V. Sahasrabuddhe, Barry I. Graubard, Susan Jick, Katherine A. McGlynn. Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer Epidemiology 2016; 43: 105 doi: 10.1016/j.canep.2016.06.009
|
| 21 |
Sema Nickbakhsh, E. Carol McWilliam Leitch, Shanley Smith, Chris Davis, Sharon Hutchinson, William L. Irving, John McLauchlan, Emma C. Thomson. Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study. Epidemiology and Infection 2023; 151 doi: 10.1017/S0950268823000377
|
| 22 |
Julia Middelhoff, Hubert Scheidbach, Ingo Gastinger, Frank Meyer. Präkanzerosen und Malignome des Gastrointestinaltrakts. coloproctology 2021; 43(4): 284 doi: 10.1007/s00053-020-00502-4
|
| 23 |
Jianfeng Wang, Xiaogang Li. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 33(12): 1603 doi: 10.1097/MEG.0000000000002040
|
| 24 |
Julie Konfortion, Victoria H. Coupland, Hemant M. Kocher, William Allum, Melanie J. Grocock, Ruth H. Jack. Time and deprivation trends in incidence of primary liver cancer subtypes in England. Journal of Evaluation in Clinical Practice 2014; 20(4): 498 doi: 10.1111/jep.12188
|
| 25 |
Dingqiang Lu, Qiuda Xu, Guangchang Pang, Fuping Lu. A novel electrochemical immunosensor based on Au nanoparticles and horseradish peroxidase signal amplification for ultrasensitive detection of α-fetoprotein. Biomedical Microdevices 2018; 20(2) doi: 10.1007/s10544-018-0291-7
|
| 26 |
Zhiming Xiang, Qianwen Liang, Changhong Liang, Guimian Zhong. The Correlation of Contrast-Enhanced Ultrasound and MRI Perfusion Quantitative Analysis in Rabbit VX2 Liver Cancer. Cell Biochemistry and Biophysics 2014; 70(3): 1859 doi: 10.1007/s12013-014-0143-x
|
| 27 |
Christopher D. Byrne, Giovanni Targher. NAFLD: A multisystem disease. Journal of Hepatology 2015; 62(1): S47 doi: 10.1016/j.jhep.2014.12.012
|
| 28 |
Silvia Affo, Le-Xing Yu, Robert F. Schwabe. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annual Review of Pathology: Mechanisms of Disease 2017; 12(1): 153 doi: 10.1146/annurev-pathol-052016-100322
|
| 29 |
K. T. Tran, Ú. C. McMenamin, B. Hicks, P. Murchie, A. P. Thrift, H. G. Coleman, L. Iversen, B. T. Johnston, A. J. Lee, C. R. Cardwell. Proton pump inhibitor and histamine‐2 receptor antagonist use and risk of liver cancer in two population‐based studies. Alimentary Pharmacology & Therapeutics 2018; 48(1): 55 doi: 10.1111/apt.14796
|
| 30 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD011649
|